Ulinastatin is a urinary trypsin inhibitor, classified as a serine protease inhibitor that is primarily used to treat severe sepsis and acute pancreatitis by inhibiting the release of inflammatory mediators.… Read more
Ulinastatin is a urinary trypsin inhibitor, classified as a serine protease inhibitor that is primarily used to treat severe sepsis and acute pancreatitis by inhibiting the release of inflammatory mediators. This category features high-quality reference standards for the Ulinastatin API, alongside its pharmacopeial and non-pharmacopeial impurities and related stable isotope-labelled compounds. Pharmaceutical and clinical laboratories rely on these reference materials for essential tasks such as impurity profiling, method validation, and rigorous quality control of drug substances. By utilizing these precise analytical standards, researchers can ensure the accuracy of their testing protocols during drug development and regulatory compliance processes. The availability of these labelled compounds and identified impurities supports the characterization and quantification required for the analysis of Ulinastatin in complex biological or chemical matrices.